Hope for long COVID brain fog: new drug trial launches
NCT ID NCT05764538
First seen Mar 23, 2026 · Last updated Apr 24, 2026 · Updated 4 times
Summary
This study tests a drug called DAOIB to see if it can help with memory and thinking problems caused by long COVID. About 40 adults with long COVID and brain fog will take the drug for 24 weeks. Researchers will check their thinking skills, mood, and quality of life every 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Chang Gung Memorial Hospital
RECRUITINGKaohsiung City, 886, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.